Royal Sense has launched new product ‘Stergic Chikungunya IgG/IgM Rapid Test’ available for sale from August 21, 2024. The Chikungunya rapid test is a diagnostic tool designed to detect the presence of Chikungunya virus antibodies in a blood sample. This test is typically used to diagnose recent or current infections with Chikungunya virus, which is transmitted by mosquitoes and causes fever, joint pain, and other symptoms.
The rapid test works by identifying specific antibodies produced by the immune system in response to the virus. Results are usually available within 15-20 minutes, making it a quick and efficient method for preliminary diagnosis. The test is valuable in areas where Chikungunya is prevalent, allowing for timely medical intervention. It is important to follow up with confirmatory testing and clinical evaluation for accurate diagnosis and treatment.
Royal Sense is suppliers of high quality goods that meet international standards required for hospitals, laboratories, institutions and clinics to provide health services.
| Company Name | CMP |
|---|---|
| Redington | 228.95 |
| Adani Enterprises | 2229.30 |
| Amrapali Industries | 17.40 |
| Rashi Peripheral | 476.65 |
| PDS | 298.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: